These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 8959034)

  • 21. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of sigma receptors and metabolic responses to sigma ligands in the brain.
    London ED
    NIDA Res Monogr; 1993; 133():55-68. PubMed ID: 8232516
    [No Abstract]   [Full Text] [Related]  

  • 24. Repeated methamphetamine-treatment alters brain sigma receptors.
    Itzhak Y
    Eur J Pharmacol; 1993 Jan; 230(2):243-4. PubMed ID: 8422906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo labeling of sigma receptors in mouse brain with [3H]4-phenyl-1-(4-phenylbutyl)piperidine.
    Hashimoto K; Scheffel U; London ED
    Synapse; 1995 May; 20(1):85-90. PubMed ID: 7624833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by p-chloroamphetamine of the conversion of 5-hydroxytryptamine to 5-hydroxyindoleacetic acid in rat brain.
    Fuller RW; Hines CW
    J Pharm Pharmacol; 1970 Aug; 22(8):634-5. PubMed ID: 4394546
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R; de Montigny C; Debonnel G
    Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic-dopaminergic interactions: implications for hyperkinetic disorders.
    Gabay S
    Adv Exp Med Biol; 1981; 133():585-601. PubMed ID: 6172019
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased behavioural activity of rats in forced swimming test after partial denervation of serotonergic system by parachloroamphetamine treatment.
    Häidkind R; Eller M; Kask A; Harro M; Rinken A; Oreland L; Harro J
    Neurochem Int; 2004 Oct; 45(5):721-32. PubMed ID: 15234115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cis and trans isomers of 1-amino-2-(p-chlorophenyl)cyclohexane, conformationally restricted analogs of p-chloroamphetamine, on 5-hydroxyindoles in rat brain.
    Fuller RW; Snoddy HD; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):349-52. PubMed ID: 6187054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.
    Cobos EJ; del Pozo E; Baeyens JM
    J Neurochem; 2007 Aug; 102(3):812-25. PubMed ID: 17419803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic treatment with haloperidol or fluphenazine decanoate: regional effects on dopamine and serotonin metabolism in primate brain.
    Bacopoulos NG; Bustos G; Redmond DE; Roth RH
    J Pharmacol Exp Ther; 1982 Apr; 221(1):22-8. PubMed ID: 6174729
    [No Abstract]   [Full Text] [Related]  

  • 33. NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profile.
    Clissold DB; Pontecorvo MJ; Jones BE; Abreu ME; Karbon EW; Erickson RH; Natalie KJ; Borosky S; Hartman T; Mansbach RS
    J Pharmacol Exp Ther; 1993 May; 265(2):876-86. PubMed ID: 8098765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
    Hara H; Tanaka K; Harada Y; Sukamoto T
    J Pharmacol Exp Ther; 1994 May; 269(2):799-805. PubMed ID: 8182548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
    Monnet FP; de Costa BR; Bowen WD
    Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    Henderson MG; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1993 Oct; 267(1):417-24. PubMed ID: 8229770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
    Matsuno K; Matsunaga K; Senda T; Mita S
    J Pharmacol Exp Ther; 1993 May; 265(2):851-9. PubMed ID: 8496830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
    Benmansour S; Brunswick DJ
    Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.